Study Comparing the Effects of Latanoprostene Bunod and Timolol on Retinal Blood Vessel Density and Visual Acuity
Conditions:   OAG - Open-Angle Glaucoma;   OHT - Ocular Hypertension Interventions:   Drug: Latanoprostene bunod 0.024% QD;   Drug: Timolol maleate 0.5% BID Sponsors:   University of California, San Diego;   Bausch & Lomb Incorporated Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 30, 2019 Category: Research Source Type: clinical trials

Optimizing Timolol Maleate Treatment of Infantile Hemangioma by Doppler Ultrasound Examination
Condition:   Infantile Hemangioma Intervention:   Drug: Timolol Maleate 0.5% Oph Soln Sponsor:   XiaoXi Lin Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2019 Category: Research Source Type: clinical trials